National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Renal CancerRenal Cell CarcinomaRenal Cell Cancer Metastatic
Trial Locations (27)

Unknown

RECRUITING

Amsterdam UMC locatie VUMC, Amsterdam

RECRUITING

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

RECRUITING

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

RECRUITING

Meander Medisch Centrum, Amersfoort

RECRUITING

Gelre ziekenhuis, Apeldoorn

RECRUITING

Rijnstate, Arnhem

RECRUITING

Amphia Ziekenhuis, Breda

RECRUITING

Deventer Ziekenhuis, Deventer

RECRUITING

Albert Schweitzer, Dordrecht

RECRUITING

Catharina ziekenhuis, Eindhoven

RECRUITING

Maxima MC, Eindhoven

RECRUITING

Treant, Emmen

RECRUITING

UMCG, Groningen

RECRUITING

Spaarne Gasthuis, Haarlem

RECRUITING

Tergooi MC, Hilversum

RECRUITING

Medisch Centrum Leeuwarden, Leeuwarden

RECRUITING

Maastricht UMC, Maastricht

RECRUITING

St Antonius Ziekenhuis, Nieuwegein

RECRUITING

Canisius Wilhelmina Ziekenhuis, Nijmegen

RECRUITING

Bravis ziekenhuis, Roosendaal

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

Maasstad ziekenhuis, Rotterdam

RECRUITING

St. Franciscus ziekenhuis, Rotterdam

RECRUITING

Haaglanden Medisch Centrum, The Hague

RECRUITING

UMC Utrecht, Utrecht

RECRUITING

Viecuri, Venray

RECRUITING

Isala, Zwolle

Sponsors
All Listed Sponsors
collaborator

Comprehensive Cancer Centre The Netherlands

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Ipsen

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

PROspective Renal Cancer Cohort Foundation

OTHER